ORASURE TECHNOLOGIES INC

Develops and distributes point-of-care diagnostic tests and sample collection devices.

OSUR | NDAQ

Overview

Corporate Details

ISIN(s):: US68554V1089
LEI:
Country:: United States of America
Address:: 220 E FIRST ST, 18015 BETHLEHEM
Website:: https://www.orasure.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OraSure Technologies, Inc. is a leader in the development, manufacture, and distribution of point-of-care diagnostic tests and sample collection devices. Together with its subsidiaries, including DNA Genotek and Sherlock Biosciences, the company provides innovative solutions for discovering and detecting critical medical conditions. Its product portfolio features rapid diagnostic tests for infectious diseases such as HIV and HCV, as well as sample collection and stabilization technologies. OraSure focuses on improving healthcare access and quality through effortless, often oral fluid-based, testing solutions. The company's products are sold globally to a diverse market, including clinical laboratories, hospitals, public health organizations, government agencies, pharmaceutical companies, and direct to consumers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ORASURE TECHNOLOGIES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ORASURE TECHNOLOGIES INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ORASURE TECHNOLOGIES INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ANTEROGEN CO., LTD. Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.	South Korea	065660
Antibiotice S.A. Develops and manufactures generic medicines and APIs, specializing in anti-infectives.	Romania	ATB
Apellis Pharmaceuticals, Inc. Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.	United States of America	APLS
Apimeds Pharmaceuticals US, Inc. Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.	United States of America	APUS
Apogee Therapeutics, Inc. Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.	United States of America	APGE
Apollomics Inc. A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.	United States of America	APLM
Apontis Pharma AG German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.	Germany	APPH
APPLIED DNA SCIENCES INC Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.	United States of America	APDN
Applied Therapeutics, Inc. Develops treatments for rare metabolic and central nervous system (CNS) disorders.	United States of America	APLT
Aprea Therapeutics, Inc. Developing precision cancer therapies targeting DNA Damage Response for solid tumors.	United States of America	APRE